metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Información de la revista
Vol. 11. Núm. 1.
Páginas 128-129 (enero - febrero 2012)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1320
Vol. 11. Núm. 1.
Páginas 128-129 (enero - febrero 2012)
Open Access
Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Visitas
1320
Heriberto Medina-Franco
,
Autor para correspondencia
herimd@hotmail.com

Correspondence and reprint request:
, Daniel Zamora-Valdés*, Ariadne Sánchez-Ramón*, Gabriela Trejo-Gómez*
* Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), México, D.F
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Abstract

Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a consequence of this treatment modality. Patient do not experiment any associated morbidity.

keywords:
Hyperthermic chemotherapy
Citoreduction
Peritoneal carcinomatosis
Side effects
Liver toxicity
Liver damage
Texto completo
Case Report

A 51-year old female with systemic lupus erythematosus was diagnosed with high-grade serous ovarian carcinoma stage IIIC in December 2009. Neoadyuvant chemotherapy with carboplatin and taxol was initiated and optimal interval cytoreduction was performed in June 2010. During follow up, asymptomatic elevation of the serum marker (CA-125), lead to the discovery of recurrent disease, predominantly in the right upper quadrant with good response to repeated chemotherapy. Secondary optimal cytoreduction was peformed in May 2011 with intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC). Peritoneal carcinomatosis index was 24 and a completeness cytoreduction index of 1 was achieved. Mitomycin 15 mg/m2 was administered at 42 °C during 75 min.

After the washout of the chemotherapeutic agent from the peritoneal cavity, a prominent 3 cm vesicle was noted in the anterior surface of segment V surrounded by reddish areas in segments IVb, V and VI, simulating a second degree skin burn (Figure 1). This lesion was not present at initial exploration. Preoperative liver function tests were normal:

Figure 1.

Liver surface after hyperthermic intraperitoneal chemotherapy. A. Blister. B. Reddish areas simulating a second degree skin burn.

(0.08MB).

  • Total bilirubin 0.30 mg/dL.

  • Direct bilirubin 0.10 mg/dL.

  • ALT 10 U/L.

  • AST 18 U/L.

  • Alkaline phosphatase 93 U/L, and

  • Albumin 4.3 g/d.

Postoperative studies showed a mild increase in transaminase levels and hypoalbuminemia as a result of a catabolic state:

  • Total bilirubin 0.35 mg/dL.

  • Direct bilirubin 0.14 mg/dL.

  • ALT 80 U/L.

  • AST 127 U/L.

  • Alkaline phosphatase 51 U/L, and

  • Albumin 2.4 g/dL.

Hepatic damage in patients with burn injuries has been extensively studied,1 however, the description of direct burn injuries to the liver has not been described in the literature. HIPEC is an alternative for patients with chemosensitive peritoneal carcinomatosis due to colorectal, ovarian or appendiceal tumors in whom complete cytoreduction is not feasible.2 Cytotoxic damage is potentiated by moderare hyperthermia. Direct heat damage to intra-abdominal organs associated with this therapy is illustrated in this case, which fortunately led to no morbidity to the patient.

References
[1.]
Song J., Finnerty C.C., Herndon D.N., Boehning D..
Jeschke MG. Severe burn-induced endoplasmic reticulum stress and hepatic damage in mice.
Moi Med, 15 (2009), pp. 316-320
[2.]
Helm C.W..
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
Oncologist, 14 (2009), pp. 683-694
Copyright © 2012. Fundación Clínica Médica Sur, A.C.
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos